APONTIS PHARMA AG

Highlights Apontis Pharma AG Deutsche Boerse AG

Equities

APPH

DE000A3CMGM5

Market Closed - Deutsche Boerse AG Other stock markets 08:16:32 17/05/2024 BST			5-day change	1st Jan Change
9.24 ^EUR	+1.32%		+7.44%	+97.44%

04-05	Apontis Bags Distribution Deal with Novartis Unit for Two Asthma Medications	MT
03-28	Apontis Pharma AG Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Apontis Bags Distribution Deal with Novartis Unit for Two Asthma Medications	04-05	MT
Apontis Pharma AG Reports Earnings Results for the Full Year Ended December 31, 2023	03-28	CI
Apontis Pharma Provides Earnings Guidance for the Full Year 2023	11-09	CI
Apontis Pharma AG Reports Earnings Results for the Half Year Ended June 30, 2023	10/08/23	CI
AstraZeneca Cancels Lung Disease Drug Co-promotion Deal With Apontis Pharma	01/08/23	MT
Aontis Pharma AG Launches Single Pill Finder and Distribution of Single Pill Rosazimib	29/06/23	CI
APONTIS PHARMA in Q1 2023 records decline in sales and earnings as expected – 2023 as a transition year in focusing on Single Pills	09/05/23	EQ
Apontis Pharma Ag Provides Revenue Guidance for the Year 2023	02/05/23	CI
Apontis Pharma AG Reports Earnings Results for the Full Year Ended December 31, 2022	30/03/23	CI
APONTIS PHARMA with successful financial year 2022: Revenue and EBITDA forecast slightly exceeded according to preliminary calculations	09/03/23	EQ
Apontis Pharma In-Licenses Single Pill for Hypertension, Hyperlipidemia Treatment	31/01/23	MT
APONTIS PHARMA extends portfolio for the treatment of hypertension and hyperlipidemia by in-licensing a new Single Pill	31/01/23	EQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer